Axon price target lowered to $682 from $702 at Barclays

Barclays lowered the firm’s price target on Axon (AXON) to $682 from $702 and keeps an Overweight rating on the shares. The company’s updated long-term targets came in above expectations, the analyst tells investors in a research note. The firm says all of Axon’s business lines are expected to contribute to growth.